Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies

Christoph Krisp, Sarah A. Randall, Matthew J. McKay, Mark P. Molloy*

*Corresponding author for this work

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

The widespread clinical adoption of protein biomarkers with diagnostic, prognostic and/or predictive value remains a formidable challenge for the biomedical community. From discovery to validation, the path to biomarkers of clinical relevance abounds with many protein candidates, yet so few concrete examples have been substantiated. In this review, we focus on the recent adoption of selected reaction monitoring (SRM) of plasma proteins in the path to clinical use for a broad range of diseases including cancer, cardiovascular disease, genetic disorders and various metabolic disorders. Recent progress reveals a promising outlook for clinical applications using SRM, which now provides the routine analysis of clinically relevant protein markers at low nanogram per millilitre in plasma.

Original languageEnglish
Pages (from-to)42-59
Number of pages18
JournalProteomics - Clinical Applications
Volume6
Issue number1-2
DOIs
Publication statusPublished - Jan 2012

Fingerprint Dive into the research topics of 'Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies'. Together they form a unique fingerprint.

  • Cite this